Byung Lee

Company: NeoImmuneTech Inc.
Job title: Senior Vice President & Chief Scientific Officer
Seminars:
IL-7 therapy: Oncology and beyond 11:30 am
NT-I7 (efineptakin alfa, a long-acting human IL-7) clinical development NT-I7 in combination with checkpoint inhibitors Potential clinical biomarkers in IL-7 treatmentRead more
day: Day One